Skip to main content
Clinical Trials/ISRCTN14567609
ISRCTN14567609
Completed
Phase 3

Improving outcomes in fistula intervention: A prospective, patient blinded, phase III, randomised controlled trial of drug eluting balloons in the angioplasty of native haemodialysis access arterio-venous fistula outflow stenosis

niversity Hospital Birmingham NHS Foundation Trust0 sites92 target enrollmentJanuary 20, 2016

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Renal failure
Sponsor
niversity Hospital Birmingham NHS Foundation Trust
Enrollment
92
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 20, 2016
End Date
April 30, 2020
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity Hospital Birmingham NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Arteriovenous (AV) fistulas with stenosis requiring percutaneous angioplasty identified on routine diagnostic imaging or causing clinical concern on dialysis
  • 2\. Fistula has been in use for at least 1 month and is more than 6 weeks old
  • 3\. Brachiocephalic AV fistula
  • 4\. Brachiobasilic AV fistula
  • 5\. Radiocephalic AV fistula (both proximal and distal)
  • 6\. Aged 18 years or over
  • 7\. Index lesion is less then the length of the DEB, and the reference vessel diameter is appropriate for treatment with the size range of DEB (4mm ­ 8mm diameter)
  • 8\. Capacity to give valid informed consent

Exclusion Criteria

  • 1\. Allergy to iodinated Intravenous contrast
  • 2\. Allergy to Paclitaxel
  • 3\. Prosthetic grafts
  • 4\. Long or tandem lesions that cannot be treated with a single DEB
  • 5\. Thrombosed Arterio­Venous fistulas
  • 6\. Women who are breastfeeding, pregnant or intending to become pregnant
  • 7\. Participants of child­bearing age who are unwilling to use a reliable form of contraception for the duration of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials